← Open Payments lookup

DENIS MEE-LEE: Open Payments

NPI 1730132416 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$99,484 in 298 payments from 14 companies in 2025. Trend: 2023 $91,716 · 2024 $86,507 · 2025 $99,484

Speaker / faculty: $74,021Consulting: $12,500Food & beverage: $6,895Travel & lodging: $5,944Education: $124
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.53$26,989
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)60$21,250
Otsuka America Pharmaceutical, Inc.30$17,626
Neurocrine BioSciences, Inc.28$17,085
ABBVIE INC.35$14,727
Alkermes, Inc.27$497
Vanda Pharmaceuticals Inc.17$340
E.R. Squibb & Sons, L.L.C.13$298
Lundbeck LLC16$294
Janssen Pharmaceuticals, Inc12$215

Products named: CAPLYTA, ABILIFY MAINTENA, INGREZZA, VRAYLAR, UZEDY, AUSTEDO XR, ARISTADA, REXULTI.

Industry payments across HI — which companies pay providers there.